Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is polyploidy an important genotoxic lesion?

I D Mitchell1, T R Lambert, M Burden

  • 1Toxicology Department, SmithKline Beecham Pharmaceuticals, Welwyn, Herts, UK.

Mutagenesis
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re: Infection prevention in implant surgery - A review of the surgical evidence, guidelines and a checklist.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
Same author

Hyperactive hypothalamus, motivated and non-distractible chronic overeating in ADAR2 transgenic mice.

Genes, brain, and behavior·2013
Same author

Communications between bone cells and hematopoietic stem cells.

Archives of biochemistry and biophysics·2008
Same author

Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction.

Diabetic medicine : a journal of the British Diabetic Association·2007
Same author

Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.

HIV medicine·2005
Same author

Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin.

The Journal of infection·2005
Same journal

How genotoxic is the indoor air environment?

Mutagenesis·2026
Same journal

Unveiling the Genotoxic Safety and Antioxidant-Mediated DNA Protective Mechanisms of Triammonium Citrate: An Integrated In Vitro and In Silico Approach.

Mutagenesis·2026
Same journal

Nutritional maternal factors affect the frequency of DNA damage in newborns.

Mutagenesis·2026
Same journal

Potassium bromate as a probable human Carcinogen: multi-organ toxicity and chemopreventive potential of dietary antioxidants-a comprehensive review.

Mutagenesis·2026
Same journal

DNA damage in the leukocytes of nanocomposite-exposed workers.

Mutagenesis·2026
Same journal

Ultra-Processed Foods and Diet Quality in Long COVID: Associations with Symptom Burden, DNA Damage, and Inflammation.

Mutagenesis·2026
See all related articles

Polyploidy induction by pharmaceuticals is common, often occurring at non-toxic levels. This genetic lesion is important only if induced at therapeutic concentrations.

Area of Science:

  • Genotoxicity
  • Molecular Toxicology
  • Chromosomal Aberrations

Background:

  • The role of polyploidy as a genotoxic lesion is not well-established.
  • Limited data and no reviews exist on polyploidy in routine genotoxicity screening.

Purpose of the Study:

  • To clarify the significance of polyploidy as a genotoxic lesion.
  • To analyze spontaneous and induced polyploidy in human lymphocytes.

Main Methods:

  • Literature review of polyploidy induction.
  • Analysis of historical database for metaphase analysis.
  • Testing pharmaceutical compounds for polyploidy induction in cultured human lymphocytes.

Main Results:

  • Polyploidy was induced by ~40% of tested pharmaceutical compounds.

Related Experiment Videos

  • Induced polyploidy often occurred at non-toxic concentrations with clear threshold levels.
  • Spontaneous polyploidy was rare (0.1-0.3%) and distinct from induced heteroploidy.

    • Conclusions:

    • Polyploidy induction is common but typically occurs at non-toxic levels.
    • Polyploidy induction is likely due to non-DNA targets, explaining threshold effects.
    • Polyploidy should be scored as accessory data, significant only at therapeutic levels.